05/13/2024
4:04 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:15 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G | |
11/09/2023
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/02/2023
4:51 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Robinson James A. Jr. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2023
4:08 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Kirk Allan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2023
6:30 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
6:09 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
3:42 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:05 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
6:51 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2023
11:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
05/22/2023
12:26 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
